A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression
Clinical trial NCT06259526 · COMPLETED
Trial details
- NCT number
- NCT06259526
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-26
- Primary completion
- 2024-10-23
- Enrollment
- 267
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.